Design and synthesis of peptides passing through the blood-brain barrier

Bulletin of the Chemical Society of Japan

Volumn 71, Issue 3, 1998, Pages 699-709

  Wakamiya, Tateaki ^a   Kamata, Makoto ^b   Kusumoto, Shoichi ^b   Kobayashi, Hiroyuki ^c   Sai, Yoshimichi ^c   Tamai, Ikumi ^c   Tsuji, Akira ^c  

^a KINKI UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID COMPOSITION; ARTICLE; BLOOD BRAIN BARRIER; DRUG DESIGN; DRUG PENETRATION; DRUG TRANSPORT; DRUG UPTAKE; ENZYME DEGRADATION; LIPOPHILICITY; MEMBRANE PERMEABILITY; METHYLATION; MOLECULAR SIZE; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; STRUCTURE ACTIVITY RELATION;

EID: 0031981341     PISSN: 00092673     EISSN: None     Source Type: Journal    
DOI: 10.1246/bcsj.71.699     Document Type: Article

References (21)

1. T. Terasaki, K. Hirai, H. Sato, Y. S. Kang, and A. Tsuji, J. Pharmacol. Exp. Ther., 251, 351 (1989).
2. T. Terasaki, Y. Deguchi, H. Sato, K. Hirai, and A. Tsuji, Pharm. Res., 8, 815 (1991).
3. T. Shimura, S. Tabata, T. Ohnishi, T. Terasaki, and A. Tsuji, J. Pharmacol Exp. Ther., 258, 459 (1991).
4. T. Shimura, S. Tabata, T. Ohnishi, T. Terasaki, Y. Deguchi, and A. Tsuji, J. Pharm. Pharmacol., 44, 583 (1992).
5. A. Tsuji, "Trends and Future Perspectives in Peptides and Protein Drug Delivery." ed by V. H. L. Lee, M. Hashida, and Y. Mizushima, Harwood Academic Publishers, Switzerland (1995), pp. 153-174.
6. α-methyltyrosine; Oda: 1,8-octanediamine; Pda: 1,5-pentanediamine; TEA: triethylamine; TES: triethylsilane; TFA: trifluoroacetic acid; THF: tetrahydrofuran; Ts: p-toluenesulfonyl or tosyl; Z: benzyloxycarbonyl; ZOSu: N-(benzyloxycarbonyloxy)succinimide.
7. A part of this work was presented in "the 31st Symposium on Peptide Chemistry," Akashi, October, 1993, and reported in "Peptide Chemistry 1993," ed by Y. Okada, Protein Research Foundation, Osaka (1994), pp. 213-216.
8. A part of this work was presented in "the 31st Symposium on Peptide Chemistry," Akashi, October, 1993, and reported in "Peptide Chemistry 1993," ed by Y. Okada, Protein Research Foundation, Osaka (1994), pp. 213-216.
9. S. T. Cheung and N. L. Benoiton, Can. J. Chem., 55, 906 (1977).
10. P. A. Grieco and Ali Bahsas, J. Org. Chem., 52, 5746 (1987).
11. M. Waki, Y. Kitajima, and N. Izumiya, Synthesis, 1981, 266.
12. A. Tsuji, T. Terasaki, Y. Takabatake, Y. Tenda, I. Tamai, T. Yamashima, S. Moritani, T. Tsuruo, and J. Yamashita, Life Sci., 51, 1427 (1992).
13. A. Tsuji, I. Tamai, A. Sakata, Y. Tenda, and T. Terasaki, Biochem. Pharmacol., 46, 1096 (1993).
14. Y. Sai, M. Kajita, I. Tamai, M. Kamata, T. Wakamiya, and A. Tsuji, J. Neurochem., in submission (1997).
15. C. C. W. Hughes and P. L. Rantos, Brain Res., 480, 126 (1989).
16. I. Tamai, Y. Sai, H. Kobayashi, M. Kamata, T. Wakamiya, and A. Tsuji, J. Pharmacol. Exp. Ther., 280, 410 (1997).
17. Silica gel was pre-washed with the eluent before the use.
18. 1HNMR measurement.
19. g-Ts protection.
20. D and elemental analysis were not carried out.
21. M. E. Parham and G. M. Koudon, Biochem. Biophys. Res. Commun., 80, 1 (1978).